Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccine for B-cell malignancies

Vaccine for B-cell malignancies

US Patent 6312718 · Granted Nov 6, 2001

Estimated economic value: $3,627,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof2025
BAFF-R antibodies and uses thereof2024
Therapeutic cancer vaccine containing tumor-associated neoantigens and immunosti2023
PARP-1 and methods of use thereof2023
Anti-BAFF receptor antibodies and uses thereof2023
Antibody variable domains and antibody constructs2023
BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof2021
BAFF-R antibodies and uses thereof2021
Compositions and methods for reducing C/EBP homologous protein activity in myelo2017
Methods for treatment of inflammatory and infectious viral diseases2015
Methods for treatment of ocular diseases2014
Defensin-antigen fusion proteins2014